Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSPORT: RBC Transfusion in Cancer Patients with Septic Shock
NCT03837171Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2019
- Primary completion
- Feb 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of red blood cell transfusion in septic shock and anemia (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Tissue oxygenation (lactate clearance) at 12 hours. Started Mar 2019; status: completed.
02
Drugs
red blood cell transfusion
03
Conditions
septic shockanemia
Beyond the preview
Go deeper on NCT03837171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837171.